Deutsche Bank Ag\ Novartis Ag Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Novartis Ag stock. As of the latest transaction made, Deutsche Bank Ag\ holds 48,542 shares of NVS stock, worth $5.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,542

Previous 48,542 -0.0%

Holding current value

$5.23 Million

Previous $5.17 Million 8.05%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$95.27 - $108.47 $10,479 - $11,931	-110 Reduced 0.23%	48,542 $4.7 Million
Q4 2023 Feb 14, 2024	SELL	$92.27 - $101.54 $146,432 - $161,143	-1,587 Reduced 3.16%	48,652 $4.91 Million
Q3 2023 Nov 09, 2023	SELL	$94.73 - $105.13 $72,089 - $80,003	-761 Reduced 1.49%	50,239 $5.12 Million
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $4.17 Million - $4.73 Million	45,066 Added 759.45%	51,000 $5.15 Million
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $2,881 - $3,341	-36 Reduced 0.6%	5,934 $545,000
Q4 2022 Feb 13, 2023	SELL	$75.55 - $92.52 $3,173 - $3,885	-42 Reduced 0.7%	5,970 $541,000
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $1,119 - $1,308	15 Added 0.25%	6,012 $457,000
Q1 2022 May 13, 2022	SELL	$80.11 - $90.62 $741,498 - $838,778	-9,256 Reduced 60.68%	5,997 $526,000
Q4 2021 Feb 11, 2022	SELL	$79.7 - $88.13 $89,742 - $99,234	-1,126 Reduced 6.87%	15,253 $1.34 Million
Q3 2021 Nov 04, 2021	SELL	$81.78 - $95.14 $40,562 - $47,189	-496 Reduced 2.94%	16,379 $1.34 Million
Q2 2021 Aug 11, 2021	SELL	$85.24 - $94.15 $4.43 Million - $4.9 Million	-52,026 Reduced 75.51%	16,875 $1.54 Million
Q1 2021 May 13, 2021	SELL	$83.5 - $98.47 $2.42 Million - $2.85 Million	-28,964 Reduced 29.6%	68,901 $5.89 Million
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $786,321 - $951,098	10,072 Added 11.47%	97,865 $9.24 Million
Q3 2020 Nov 12, 2020	BUY	$82.14 - $91.0 $404,785 - $448,448	4,928 Added 5.95%	87,793 $7.64 Million
Q2 2020 Aug 13, 2020	BUY	$80.93 - $91.1 $516,576 - $581,491	6,383 Added 8.35%	82,865 $7.24 Million
Q1 2020 May 14, 2020	SELL	$70.67 - $99.01 $147,205 - $206,237	-2,083 Reduced 2.65%	76,482 $6.31 Million
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $718,240 - $812,075	8,515 Added 12.16%	78,565 $7.44 Million
Q3 2019 Nov 14, 2019	BUY	$85.54 - $94.26 $444,465 - $489,774	5,196 Added 8.01%	70,050 $6.08 Million
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $1.17 Million - $1.44 Million	15,529 Added 31.48%	64,854 $5.92 Million
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $37.9 Million - $43.4 Million	-503,849 Reduced 91.08%	49,325 $4.74 Million
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $22.1 Million - $24.6 Million	300,188 Added 118.66%	553,174 $47.5 Million
Q3 2018 Dec 21, 2021	BUY	$66.94 - $77.43 $2.21 Million - $2.55 Million	32,952 Added 14.98%	252,986 $21.8 Million
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $28.2 Million - $32.6 Million	-421,169 Reduced 65.68%	220,034 $19 Million
Q2 2018 Apr 21, 2020	BUY	$64.91 - $73.36 $242,568 - $274,146	3,737 Added 0.59%	641,203 $48.4 Million
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $37.5 Million - $42.4 Million	577,663 Added 965.94%	637,466 $48.2 Million
Q1 2018 Oct 18, 2019	BUY	$70.39 - $84.15 $263,047 - $314,468	3,737 Added 6.67%	59,803 $4.83 Million
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $2.43 Million - $2.9 Million	34,491 Added 159.87%	56,066 $4.53 Million
Q4 2017 Feb 14, 2018	SELL	$72.33 - $77.64 $987,159 - $1.06 Million	-13,648 Reduced 38.75%	21,575 $1.81 Million
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $2.61 Million - $2.72 Million	35,223	35,223 $3.02 Million

Others Institutions Holding NVS

# of Institutions

1,448

Shares Held

130M

Call Options Held

999K

Put Options Held

1.32M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $232B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account